Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 3—March 2014
Research

Comparison of Imported Plasmodium ovale curtisi and P. ovale wallikeri Infections among Patients in Spain, 2005–2011

Gerardo Rojo-MarcosComments to Author , José Miguel Rubio-Muñoz, Germán Ramírez-Olivencia, Silvia García-Bujalance, Rosa Elcuaz-Romano, Marta Díaz-Menéndez, María Calderón, Isabel García-Bermejo, José Manuel Ruiz-Giardín, Francisco Jesús Merino-Fernández, Diego Torrús-Tendero, Alberto Delgado-Iribarren, Mónica Ribell-Bachs, Juan Arévalo-Serrano, and Juan Cuadros-González
Author affiliations: Príncipe de Asturias University Hospital, Madrid, Spain (G. Rojo-Marcos, J. Arévalo-Serrano, J. Cuadros-González,); Instituto de Salud Carlos III, Madrid (J.M. Rubio-Muñoz); Carlos III Hospital, Madrid (G. Ramírez-Olivencia); La Paz University Hospital, Madrid (S García-Bujalance); Doctor Negrín University Hospital, Las Palmas de Gran Canaria, Spain (R. Elcuaz-Romano); Ramón y Cajal Hospital, Madrid (M. Díaz-Menéndez); Gregorio Marañón University Hospital, Madrid (M. Calderón); Getafe University Hospital, Madrid (I. García-Bermejo); University Hospital of Fuenlabrada, Madrid (J. M. Ruiz-Giardín); Severo Ochoa University Hospital, Madrid (F.J. Merino-Fernández); University General Hospital of Alicante, Alicante, Spain (D. Torrús-Tendero); University Hospital Fundación Alcorcón, Madrid (A. Delgado-Iribarren); Hospital General de Granollers, Barcelona, Spain (M. Ribell-Bachs).

Main Article

Table 2

Microbiological characteristics of patients with imported Plasmodium ovale curtisi or Povale wallikeri infections, Spain, 2005–2011*

Characteristic P. ovale curtisi, n = 21 P. ovale wallikeri, n = 14 p value
Positive thick smear, no. (%) patients 16 (76.2) 10 (71.4) >0.999
Positive by PCR only, no. (%) patients 5 (23.8) 4 (28.6) >0.999
Parasitemia, μL 2,800 (773.25–5,484.25) 1,243.50 (337.75–6,200.00) 0.699
Mixed infection, no. (%) patients
 1† (4.8)
 1† (7.1)
 >0.999
Rapid diagnostic test result, no. positive/total no. patients (%)
Common antigen positive 4/16 (25.0) 4/12 (33.3) 0.691
P. falciparum antigen positive
 1/15 (6.7)
 2/12 (16.6)
 0.569
Leukocyte count, × 109 cells/L 7.2 (4.9–8.7) 5.5 (4.2–8.2) 0.309
Hemoglobin, g/dL 11.6 (9.7–13.6) 10.9 (9.6–12.1) 0.364
Platelet count, × 109 cells/L 126 (106.0–182.5) 91.5 (54.7–117.7) 0.031
Albumin, g/dL 3.7 (3.3–4.1) 3.4 (2.8–3.7) 0.063
Creatinine, mg/dL 0.88 (0.6–1.1) 0.97 (0.5–1.1) 0.730
Lactate dehydrogenase, IU/L 434.5 (358.7–807.7) 563 (462.5–731.7) 0.200
Aspartate aminotransferase, IU/L 24.5‡ (20.0–40.2) 31 (22–41) 0.624
Alanine aminotransferase, IU/L 25.5‡ (16.0–49.7) 23 (18.5–47.0) 0.785
Total bilirubin level, mg/dL 0.68‡ (0.6–1.2) 0.87 (0.6–1.4) 0.426

*Values are median (interquartile range) unless otherwise indicated. Boldface indicates significance.
†P. falciparum was second infection for both patients.
‡One patient had active hepatitis B virus infection.

Main Article

Page created: February 19, 2014
Page updated: February 19, 2014
Page reviewed: February 19, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external